Live Breaking News & Updates on Zydus Cadila Begins Enrolment For Phase 3 Vaccine Trial Reports

Zydus Cadila begins enrolment for  Phase 3 vaccine trial: Reports
India
Published: Friday, January 22, 2021, 11:37 [IST]
New Delhi, Jan 22: Zydus Cadila has started enrolling and dosing participants in India for the Phase 3 clinical trial of its three-dose COVID-19 vaccine ZyCoV-D, according to reports.
The trials are expected to take place across four cities - Surat, Nashik, Jaipur and Ahmedabad.
Representational Image
Zydus Cadila received DCGI s approval earlier this month to initiate Phase 3 trials in 26,000 Indian participants.
We started enrolment and dosing of participants from Saturday. The enrolment and dosing happens between 9am and 5pm, the principal investigator at a trial site, one of the two people mentioned above, said on condition of anonymity. ....

New Delhi , Briti Roy Barman , Zydus Cadila , Zydus Cadila Zyco , Healthcare Research Pvt , Imperial Hospital Research Center , Ltd At Ahmedabad , Manavata Cancer Centre At Nashik , Briti Roy , Zydus Hospitals , Healthcare Research , Swami Hospital , Cancer Centre , Imperial Hospital , Research Center , Marudhar Hospital , Breaking News , Instant Updates , Zydus Cadila Begins Enrolment For Phase 3 Vaccine Trial Reports , Coronavirus Vaccine Updates , புதியது டெல்ஹி , பிரிதி ராய் பார்மன் , ஜய்துச் காடிலா , சுகாதாரம் ஆராய்ச்சி பிரைவேட் , ஏகாதிபத்தியம் மருத்துவமனை ஆராய்ச்சி மையம் , லிமிடெட் இல் அஹமதாபாத் ,